Senate stalling derails bill to fix Canada's law on affordable generic medicines for developing countries

Area of Science:

• Public Health
• Pharmaceutical Policy
• International Trade Law

Background:

• Canada's Access to Medicines Regime (CAMR) facilitates exporting lower-cost medications.
• The CAMR is crucial for providing access to essential medicines, including HIV treatments, in developing nations.
• Flaws within the CAMR framework have hindered its effectiveness.

Purpose of the Study:

• To analyze the impact of Bill C-393 on Canada's Access to Medicines Regime (CAMR).
• To highlight the legislative efforts to improve the export of affordable medicines to developing countries.
• To examine the reasons for the legislative failure of Bill C-393.

Main Methods:

• Legislative analysis of Bill C-393.
• Review of the policy objectives of the Access to Medicines Regime.
• Examination of parliamentary proceedings related to Bill C-393.

Main Results:

• Bill C-393, intended to rectify issues within the CAMR, did not pass.
• The dissolution of Parliament on March 26, 2011, led to the bill's demise.
• The specific flaws addressed by Bill C-393 remain uncorrected within the CAMR.

Conclusions:

• The failure of Bill C-393 represents a setback for improving access to medicines in developing countries.
• The legislative process and parliamentary dissolution significantly impacted global health initiatives.
• Further legislative action is required to strengthen the CAMR and ensure its intended function.